ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS

Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection. L'invention concerne des analogues nucléosidiques...

Full description

Saved in:
Bibliographic Details
Main Authors BOYD, Steven A, COBURN, Glen A, CONDON, Stephen M
Format Patent
LanguageEnglish
French
Published 12.10.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection. L'invention concerne des analogues nucléosidiques biodisponibles par voie orale et des compositions pharmaceutiques comprenant lesdits composés. Les composés et les compositions de l'invention sont utiles pour le traitement d'infections à coronavirus, y compris une infection par le SARS-CoV-2.
Bibliography:Application Number: WO2023US17669